Hi @Lymmf,
I see you & @LesrningEachDay are discussing the Lightner trials of allogeneic MSCs in fistulizing Crohn’s, I’d just like to add that I think there are likely to be a couple of interim takeaways for MSB, despite the difference in mode of delivery, cell product etc.
First, IMO the safety responses should be of interest. Hopefully they’ll be consistent with MSB’s results to date with Crohn’s patients
Second, the treatment cell actions of assisting the Crohn’s patient’s body in closing a fistula are, as I see it, essentially regenerative in nature. Any positive results for allogeneic cell therapies in this disease may assist MSB e.g. to seek RMAT designation in connection with its own trials.
And, naturally, there may be IP licensing needed from MSB in due course. So I’ll certainly be interested in these trial results & the journal commentary, while we wait for our own.
Cheers
- Forums
- ASX - By Stock
- DREAM HF Trial Video
Hi @Lymmf, I see you & @LesrningEachDay are discussing the...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.324B |
Open | High | Low | Value | Volume |
$1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1335 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 32999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4990 | 1.225 |
3 | 8203 | 1.220 |
1 | 10643 | 1.215 |
1 | 184 | 1.205 |
3 | 101916 | 1.195 |
Price($) | Vol. | No. |
---|---|---|
1.060 | 18000 | 1 |
1.100 | 612 | 1 |
1.105 | 10536 | 2 |
1.130 | 25000 | 2 |
1.135 | 25224 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online